Important genetic NB targets that are detectable using ctDNA include (but are not limited to) gene amplifications (MYCN and ALK), chromosomal copy number changes (1p and 11q loss, and 17q gain), and epigenetic aberrations (RASSF1A and DCR2 hypermethylation)43,143. The gene discussed is ALK; the disease is neuroblastoma.